Rosie Carr Meysenburg — (2006 FDA Hearings)

To view complete transcript click here

THE FDA PSYCHOPHARMACOLOGIC DRUGS ADVISORY COMMITTEE HEARINGS 2006

DR. RUDORFER:  Thank you. We are up to speaker 20.  Rosie Carr Meysenburg

MS. MEYSENBURG:  My name is Rosie Carr Meysenburg. I am from Dallas, Texas.  I have no financial ties with anybody but my husband of 40 years.

In my handout, I have highlighted what I am speaking about here.

The first paper is a personal letter from Dr. Peter S. Jensen.  At that time, he was the head of Child & Adolescent Disorders Research Branch of

the NIMH, the National Institute of Mental Health.

He said that research indicates that antidepressants for depressed adolescents are not very effective.

The second paper is a personal letter from Dr. Larry S. Goldman, Director of the AMA, the American Medical Association.  He writes physicians

have known for many years the dangers of giving any antidepressant to patients with certain disorders.  There is a substantial risk of precipitating mania or psychosis.

The last item is a journal article from the Journal of Clinical Psychiatry researched at Yale University.  It states that 11 percent of all psychiatric hospital admissions were from antidepressant-induced mania and psychosis. It also states another area of research that would be relevant to this issue is the work of Winter and colleagues showing that Prozac and other SSRIs can simulate the effects of LSD.  In other words, this is saying for some people, taking an SSRI is the same as taking LSD.

About two million people enter a psychiatric hospital every year, 11 percent then is over 200,000 people a year who have an antidepressant-induced psychosis and who are hospitalized.  Not all are hospitalized.  Some of them have either committed suicide, a homicide, or a murder/suicide.